ELPEN is a privately owned, Greek pharmaceutical company with operations worldwide. Established in 1965, the group currently has more than 1000 employees and an annual turnover of €200 million. With state of the art production and research facilities, ELPEN specializes in the development, production and commercialization of generic products and value added medicines to more than 60 countries worldwide. All of them are manufactured under the strict EU guidelines.
|
ELPEN is a privately owned, Greek pharmaceutical company with more than 780 employees and
operations worldwide.
|